Related Experiment Video
Updated: May 5, 2026

Nutrient Regulation by Continuous Feeding for Large-scale Expansion of Mammalian Cells in Spheroids
Published on: September 25, 2016
Regulation of cell-based therapies in Europe: current challenges and emerging issues
Alessandro Blasimme1, Emmanuelle Rial-Sebbag
1INSERM UMR 1027 Département d'épidémiologie et de santé publique, Faculté de Médecine, Université Paul Sabatier-Toulouse III , Toulouse, France .
Abstract:
Europe is ready to deploy its immense capital of knowledge into the development of effective cell-based therapies and delve into the global race for translating stem cell science into regenerative medicine. But what are the challenges and the emerging issues that lay ahead the realization of Europe's enormous potential in this field? Both researchers and industrial stakeholders tend to impute the slow pace of translation to specific suboptimal features of the regulatory environment in Europe. At the same time, a host of new issues are emerging as testified by a recent public controversy regarding the provision of unproven cell therapy in Italy. We will review this topic and suggest some solutions to foster the responsible development of innovative cell-based therapies in Europe.
Related Concept Videos
Drug Control Governance: Regulatory Bodies and Their Impact
Stem Cell Culture
Forced Transdifferentiation
Artificial...
Embryonic Stem Cells
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
Regulation of Hematopoietic Stem Cells
Drug Regulation

